---
title: "Greenridge Global Remains a Buy on Cango (CANG)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286104108.md"
description: "In a report released today, William Gregozeski from Greenridge Global reiterated a Buy rating on Cango, with a price target of $3.00.Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks According to TipRanks, Gregozeski is ranked #9949 out of 12188 analysts. Currently, the analyst consensus on Cango is a Moderate Buy with an average price target of $3.00."
datetime: "2026-05-12T12:55:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286104108.md)
  - [en](https://longbridge.com/en/news/286104108.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286104108.md)
---

# Greenridge Global Remains a Buy on Cango (CANG)

In a report released today, William Gregozeski from Greenridge Global reiterated a Buy rating on Cango, with a price target of $3.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Gregozeski is ranked #9949 out of 12188 analysts.

Currently, the analyst consensus on Cango is a Moderate Buy with an average price target of $3.00.

### Related Stocks

- [CANG.US](https://longbridge.com/en/quote/CANG.US.md)

## Related News & Research

- [Cango Inc. Reports Fourth Quarter and Full Year 2025 Unaudited Financial Results | CANG Stock News](https://longbridge.com/en/news/279330686.md)
- [Cango Inc. Filed Its Annual Report on Form 20-F | CANG Stock News](https://longbridge.com/en/news/282388600.md)
- [Why This Analyst Thinks Texas Instruments Stock Is on the Path to $1 Trillion](https://longbridge.com/en/news/286957345.md)
- [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md)
- [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md)